Luke M. Miller

Luke M. Miller

Auto-generated profile, based on publicly available information

Luke M. Miller

University of Arizona, Banner University Medical Center Department of Radiology and Imaging Sciences, Tucson, AZ, United States of America

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2025 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
MRMahla Radmard
Mahla Radmard
LMLuke Miller
Luke Miller
ATArmin Tafazolimoghadam
Armin Tafazolimoghadam
SHShahram Hadidchi
Shahram Hadidchi
JHJoyce Hsu
Joyce Hsu
CACaline Azzi
Caline Azzi
BACKGROUND AND PURPOSE: The use of head CT in trauma settings has increased significantly, driven by the need to detect and monitor intracranial hemorrhages. Among intracranial hemorrhage subtypes, epidural hematomas (EDHs) are relatively uncommon but require careful evaluation due to their potential for expansion and the need for surgical intervention. This study aimed to identify risk factors for initial EDH size, subsequent enlargement, and the need for surgical intervention to guide imaging and treatment strategies. MATERIALS AND METHODS: We conducted a retrospective review of 32,401 noncontrast head CT reports from 2 trauma centers (The Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center) between 2018 and 2024. Patients with EDHs were identified using a structured search of radiology reports. Clinical, demographic, and imaging characteristics were analyzed to assess the predictors of EDH enlargement and the need for surgery. Statistical analyses included the χ2 or Fisher exact test, Mann-Whitney U test, Kruskal-Wallis H test, and logistic regression analysis. RESULTS: Among 91 cases of EDH, a larger initial EDH size was associated with arterial bleeding sources, mixed attenuation, and the spot sign. These same factors, plus a midline shift, predicted the need for initial surgery. No clinical features or comorbidities predicted a larger EDH. Follow-up imaging revealed EDH enlargement in 25/89 cases (28.1%), with SAH as the only significant predictor (OR = 2.60; 95% CI, 1.00–6.77; P = .05). The scans that demonstrated EDH enlargement were performed after a mean of 6.6 (SD 3.3) hours. Ultimately, 25/91 (27.5%) EDHs required surgical intervention; only EDH enlargement was predictive of the need for follow-up surgery after initial observation. CONCLUSIONS: The presence of concurrent SAH was the strongest predictor of EDH enlargement, and radiologists should recommend short-term monitoring of patients with EDH and SAH. Repeat CT at 6–13 hours will detect nearly all cases of EDH enlargement, which may lead to subsequent surgery. Initial large size, midline shift, arterial sources of bleeds, and active bleeding imaging findings correlated with an early surgical intervention. Future multicenter studies are needed to refine risk stratification and optimize imaging follow-up to balance patient safety and health care resource use. Graphical Abstract

28 March 2026 in European Journal of Radiology
Verified
Journal Article
Open access
LMLuke M. Miller
Luke M. Miller
HOHasan Ozgur
Hasan Ozgur
LLLicia P. Luna
Licia P. Luna
Limbic-predominant Age-related TDP-43 Encephalopathy (LATE) is a pathology-based diagnosis which represents an increasingly recognized but substantially underappreciated cause of dementia in older adults, potentially accounting for 15-25% of cases clinically diagnosed as Alzheimer's Disease. Limbic-predominant Amnestic Neurodegenerative Syndrome (LANS) is an overlapping proposed clinical diagnosis based on functional patterns of limbic-predominant neurodegeneration. This educational review examines the pathologic basis, clinical presentation, and multimodal imaging features of LATE and LANS, with emphasis on the role of radiology in the diagnostic algorithm. Both entities are characterized by relatively late presentation and an indolent course of progressive memory loss. Two diagnostic frameworks are presented: the NIA-AA ATN-based approach utilizing amyloid and tau biomarkers to establish "probable" or "possible" LATE diagnoses, and the Mayo Clinic LANS framework emphasizing functional neuroimaging to elucidate patterns of neurodegeneration. As targeted therapies improve, more accurate diagnosis is becoming increasingly important for appropriate patient selection, prognostic counseling, and future targeted therapeutic trials. Radiologists play an essential role in recognizing the characteristic imaging phenotype and raising clinical awareness of LATE and LANS.